AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Cites suicidality, worsening depression: FDA wants to strengthen warnings on 10 antidepressants.(News)

OB GYN News

| April 15, 2004 | Sullivan, Michele G. | COPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The Food and Drug Administration has asked the manufacturers of 10 antidepressant drugs to include on their labels stronger warnings about the need to monitor adult and pediatric patients for symptoms of worsening depression and the emergence of suicidal ideation.

The proposed new warnings also alert prescribers, patients, and their caregivers to the emergence of symptoms that are known to be associated with antidepressants in some patients: anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, and mania. (See box.) A causal link has not been established between the emergence of such symptoms and either worsening of depression or suicidal impulses, but medications may need to be discontinued when such symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms.

The FDA wants the new warnings on the labels of fluoxetine (Prozac), sertraline (Zoloft) paroxetine (Paxil), fluvoxamine (Luvox), citalopram (Celexa), escitalopram (Lexapro), bupropion (Wellbutrin), venlafaxine (Effexor), nefazodone (Serzone), and mirtazapine (Remeron). Letters were sent out to the companies in late March, and manufacturers are expected to institute the changes within 30 days of receipt. Dr. Russell Katz, director of FDA's Division of Neuropharmacological Drug Products, said in a teleconference.

The proposed warnings also cite the potential of antidepressants for inducing manic episodes in patients with bipolar disorder.

"It's known that the first episode of bipolar disorder is often a depressive one," Dr. Katz said. "If you treat this with antidepressants, you have the potential for invoking a manic episode, especially if you're treating with an antidepressant alone. The warning will remind physicians to take a ...

Related articles from newspapers, magazines, journals, and more
FDA Publishes New Guidelines for Packaging of Drug Products.
Magazine article from: Food & Drug Packaging Misko, George September 1, 1999 700+ words
...type of information FDA would like to see...various types of drug products. The other guidance...injection and ophthalmic drug products, liquid-based oral and topical drug products and topical delivery...other dosage forms. FDA published a draft...
FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the...
Newspaper article from: U.S. Newswire October 15, 2009 700+ words
...antiviral drugs approved by the FDA for treatment and prophylaxis...public health emergency. The FDA actively monitors the Internet...appropriate, will purchase and analyze drug products. Consumers can also visit FDA's Web site for tips about how...
FDA changes may speed approval of cancer drugs: biotech: San Diego firms...
Magazine article from: San Diego Business Journal Webb, Marion August 16, 2004 700+ words
...faster approval times. The FDA on July 16 announced plans to create an Office of Oncology Drug Products, and a new crosscutting ontology...executives have high hopes that the FDA's change will be good for...wish for more interaction with FDA officials to discuss the design...
FDA issues draft guidance regarding the incorporation of physical-chemical...
News wire article from: Mondaq Business Briefing Ball, Frederick July 20, 2009 700+ words
...S. Food and Drug Administration (FDA) issued a draft guidance for industry...Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting" (the "Draft...difficult. When incorporating PCIDs, the FDA recommends pharmaceutical manufacturers...
FDA approves two fixed-dose combination drug products for HIV-1 infection.
Newspaper article from: Medical Letter on the CDC & FDA September 5, 2004 700+ words
...Food and Drug Administration (FDA) announced the approvals of...Lester M. Crawford, acting FDA commissioner. "Simplifying...combination with other antiretroviral drug products from different classes such...and the individual products. FDA completed its review of Epzicom...
The FDA intends to take enforcement action against unapproved drug...
Magazine article from: Medical Marketing & Media February 1, 2007 700+ words
The FDA intends to take enforcement action against unapproved drug products containing quinine and persons who cause the manufacture of such products or their shipment in interstate commerce.
FDA Warns Companies to Stop Marketing Unapproved Ophthalmic Balanced Salt...
Press release article from: M2 Presswire September 24, 2008 700+ words
...Administration: FDA Warns Companies...Balanced Salt Solution Drug Products and Topical Drug...assured that all drug products are manufactured...standards required for FDA approval and that...papain drug product. FDA urges consumers who are using topical drug ...
U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical...
Press release article from: M2 Presswire June 26, 2009 700+ words
...Marshals Seize Drug Products Manufactured by...Laboratories Ltd.; FDA acts to prevent...facilities. If the FDA identifies further...with any Caraco drug products on the market...Michael Chappell, FDA acting associate...affairs. Seizure of drug products is an ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA